Molecular genetic analysis of VRK1 in mammary epithelial cells: Depletion slows proliferation in vitro and tumor growth and metastasis in vivo

Oncogenesis

Volumn 2, Issue , 2013, Pages

  Molitor, T P ^a   Traktman, P ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Breast cancer; Cell proliferation; Orthotopic xenograft; Protein kinase; Tumorigenesis; VRK1

Indexed keywords

PROTEIN; UNCLASSIFIED DRUG; VRK1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; TUMOR GROWTH; XENOGRAFT;

EUKARYOTA; MURINAE; MUS;

EID: 84879901123     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2013.11     Document Type: Article

References (36)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
2. Nichols RJ, Traktman P. Characterization of three paralogous members of the Mammalian vaccinia related kinase family. J Biol Chem 2004; 279: 7934-7946. (Pubitemid 38294681)
3. Nezu J, Oku A, Jones MH, Shimane M. Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics 1997; 45: 327-331. (Pubitemid 27467623)
4. Vega FM, Gonzalo P, Gaspar ML, Lazo PA. Expression of the VRK (vaccinia-related kinase) gene family of p53 regulators in murine hematopoietic development. FEBS Lett 2003; 544: 176-180. (Pubitemid 36628057)
5. Santos CR, Rodriguez-Pinilla M, Vega FM, Rodriguez-Peralto JL, Blanco S, Sevilla A et al. VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma. Mol Cancer Res 2006; 4: 177-185.
6. Valbuena A, Lopez-Sanchez I, Vega FM, Sevilla A, Sanz-Garcia M, Blanco S et al. Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations. Arch Biochem Biophys 2007; 465: 219-226. (Pubitemid 47284001)
7. Vega FM, Sevilla A, Lazo PA. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1. Mol Cell Biol 2004; 24: 10366-10380. (Pubitemid 39507873)
8. Kang TH, Park DY, Kim W, Kim KT. VRK1 phosphorylates CREB and mediates CCND1 expression. J Cell Sci 2008; 121(Pt 18): 3035-3041.
9. Valbuena A, Lopez-Sanchez I, Lazo PA. Human VRK1 is an early response gene and its loss causes a block in cell cycle progression. PLoS ONE 2008; 3: e1642.
10. Wiebe MS, Nichols RJ, Molitor TP, Lindgren JK, Traktman P. Mice deficient in the serine/threonine protein kinase VRK1 are infertile due to a progressive loss of spermatogonia. Biol Reprod 2010; 82: 182-193.
11. Choi YH, Park CH, Kim W, Ling H, Kang A, Chang MW et al. Vaccinia-related kinase 1 is required for the maintenance of undifferentiated spermatogonia in mouse male germ cells. PLoS ONE 2010; 5: e15254.
12. Schober CS, Aydiner F, Booth CJ, Seli E, Reinke V. The kinase VRK1 is required for normal meiotic progression in mammalian oogenesis. Mech Dev 2011; 128: 178-190.
13. Gorjanacz M, Klerkx EP, Galy V, Santarella R, Lopez-Iglesias C, Askjaer P et al. Caenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in postmitotic nuclear envelope assembly. EMBO J 2007; 26: 132-143. (Pubitemid 46094706)
14. Nichols RJ, Wiebe MS, Traktman P. The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol Biol Cell 2006; 17: 2451-2464. (Pubitemid 44011758)
15. Kang TH, Park DY, Choi YH, Kim KJ, Yoon HS, Kim KT. Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells. Mol Cell Biol 2007; 27: 8533-8546.
16. Fournier MV, Martin KJ, Kenny PA, Xhaja K, Bosch I, Yaswen P et al. Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer. Cancer Res 2006; 66: 7095-7102. (Pubitemid 44197686)
17. Martin KJ, Patrick DR, Bissell MJ, Fournier MV. Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets. PLoS ONE 2008; 3: e2994.
18. Valbuena A, Sanz-Garcia M, Lopez-Sanchez I, Vega FM, Lazo PA. Roles of VRK1 as a new player in the control of biological processes required for cell division. Cell Signal 2011; 23: 1267-1272.
19. Barcia R, Lopez-Borges S, Vega FM, Lazo PA. Kinetic properties of p53 phosphorylation by the human vaccinia-related kinase 1. Arch Biochem Biophys 2002; 399: 1-5. (Pubitemid 34848304)
20. Lopez-Borges S, Lazo PA. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein. Oncogene 2000; 19: 3656-3664. (Pubitemid 30608487)
21. Hui L, Zheng Y, Yan Y, Bargonetti J, Foster DA. Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. Oncogene 2006; 25: 7305-7310. (Pubitemid 44809096)
22. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70. (Pubitemid 30046295)
23. Valenti F, Fausti F, Biagioni F, Shay T, Fontemaggi G, Domany E et al. Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop. Cell Cycle 2011; 10: 4330-4340.
24. Hainaut P, Hollstein M. P53 and Human Cancer: the first ten thousand mutations. Adv Cancer Res 2000; 77: 81-137. (Pubitemid 29439303)
25. Wendt MK, Cooper AN, Dwinell MB. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. Oncogene 2008; 27: 1461-1471. (Pubitemid 351317456)
26. Klerkx EP, Alarcon P, Waters K, Reinke V, Sternberg PW, Askjaer P. Protein kinase VRK-1 regulates cell invasion and EGL-17/FGF signaling in Caenorhabditis elegans. Dev Biol 2009; 335: 12-21.
27. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al. Genes that mediate breast cancer metastasis to lung. Nature 2005; 436: 518-524. (Pubitemid 41112921)
28. Sanz-Garcia M, Vazquez-Cedeira M, Kellerman E, Renbaum P, Levy-Lahad E, Lazo PA. Substrate profiling of human vaccinia-related kinases identifies coilin, a Cajal body nuclear protein, as a phosphorylation target with neurological implications. J Proteomics 2011; 75: 548-560.
29. Blanco S, Santos C, Lazo PA. Vaccinia-related kinase 2 (VRK2) modulates the stress response to hypoxia mediated by TAK1. Mol Cell Biol 2007; 27: 7273-7283. (Pubitemid 47549760)
30. Mbeunkui F, Johann Jr. DJ. Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol 2009; 63: 571-582.
31. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-536. (Pubitemid 34130608)
32. Weigelt B, Peterse JL, van 't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005; 5: 591-602. (Pubitemid 41081385)
33. Vazquez-Cedeira M, Lazo PA. Human VRK2 (Vaccinia-related Kinase 2) Modulates Tumor Cell Invasion by Hyperactivation of NFAT1 and Expression of Cyclooxygenase- 2. J Biol Chem 2012; 287: 42739-42750.
34. Jacque JM, Stevenson M. The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity. Nature 2006; 441: 641-645. (Pubitemid 43927296)
35. Schneider CL, Hudson AW. The human herpesvirus-7 (HHV-7) U21 immunoevasin subverts NK-mediated cytoxicity through modulation of MICA and MICB. PLoS Pathog 2011; 7: e1002362.
36. Mostoslavsky G, Fabian AJ, Rooney S, Alt FW, Mulligan RC. Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc Natl Acad Sci USA 2006; 103: 16406-16411. (Pubitemid 44715209)